Literature DB >> 18617884

New roles for TIM family members in immune regulation.

Vijay K Kuchroo1, Valerie Dardalhon, Sheng Xiao, Ana C Anderson.   

Abstract

Members of the TIM (T-cell immunoglobulin domain and mucin domain) protein family are emerging as important regulators of immune responses. As their names imply, the TIM proteins were originally thought to be T-cell-specific molecules that served mainly to regulate T-helper-cell responses. However, the recent discovery that antigen-presenting cells also express TIM molecules and the identification of new TIM-protein ligands has expanded the known roles of the TIM proteins in immune regulation.

Mesh:

Substances:

Year:  2008        PMID: 18617884     DOI: 10.1038/nri2366

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  66 in total

1.  Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

Authors:  Shipra Gupta; Thomas B Thornley; Wenda Gao; Rafael Larocca; Laurence A Turka; Vijay K Kuchroo; Terry B Strom
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

2.  Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages.

Authors:  Kit Wong; Patricia A Valdez; Christine Tan; Sherry Yeh; Jo-Anne Hongo; Wenjun Ouyang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

3.  Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice.

Authors:  Sheng Xiao; Craig R Brooks; Chen Zhu; Chuan Wu; Johanna M Sweere; Sonia Petecka; Ada Yeste; Francisco J Quintana; Takaharu Ichimura; Raymond A Sobel; Joseph V Bonventre; Vijay K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-05       Impact factor: 11.205

4.  The significance of TIMD4 expression in clear cell renal cell carcinoma.

Authors:  Hiromu Yano; Takanobu Motoshima; Chaoya Ma; Cheng Pan; Sohsuke Yamada; Toshiyuki Nakayama; Shohei Kitada; Naohiro Fujimoto; Tomomi Kamba; Motohiro Takeya; Yoshihiro Komohara
Journal:  Med Mol Morphol       Date:  2017-06-19       Impact factor: 2.309

Review 5.  Sequence, structure, function, immunity: structural genomics of costimulation.

Authors:  Kausik Chattopadhyay; Eszter Lazar-Molnar; Qingrong Yan; Rotem Rubinstein; Chenyang Zhan; Vladimir Vigdorovich; Udupi A Ramagopal; Jeffrey Bonanno; Stanley G Nathenson; Steven C Almo
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

6.  TIM-1 signaling is required for maintenance and induction of regulatory B cells.

Authors:  M Y Yeung; Q Ding; C R Brooks; S Xiao; C J Workman; D A A Vignali; T Ueno; R F Padera; V K Kuchroo; N Najafian; D M Rothstein
Journal:  Am J Transplant       Date:  2015-02-02       Impact factor: 8.086

7.  Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.

Authors:  Sharvan Sehrawat; Amol Suryawanshi; Mitsuomi Hirashima; Barry T Rouse
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  A scaffold for signaling of Tim-4-mediated efferocytosis is formed by fibronectin.

Authors:  Juyeon Lee; Boyeon Park; Byeongjin Moon; Jeongjun Park; Hyunji Moon; Kwanhyeong Kim; Sang-Ah Lee; Deokhwan Kim; Chanhyuk Min; Dae-Hee Lee; Gwangrog Lee; Daeho Park
Journal:  Cell Death Differ       Date:  2018-11-19       Impact factor: 15.828

9.  Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.

Authors:  Shigeki Chiba; Muhammad Baghdadi; Hisaya Akiba; Hironori Yoshiyama; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Yoichiro Fujioka; Yusuke Ohba; Jacob V Gorman; John D Colgan; Mitsuomi Hirashima; Toshimitsu Uede; Akinori Takaoka; Hideo Yagita; Masahisa Jinushi
Journal:  Nat Immunol       Date:  2012-07-29       Impact factor: 25.606

Review 10.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.